Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TCP11
REST API REST API
Homo sapiens
TCP11 is differentially expressed in 111 experiments: 64 organism parts: testis, blood, ... (62 more);, 91 disease states: normal, "Aggressive, chronic myelogenous leukemia", ... (89 more);, 29 cell types 70 cell lines 15 compound treatments and 56 other conditions.
Synonyms KIAA0229, D6S230E
Orthologs ENSGALG00000002692 (Gallus gallus)   TCP11 (Bos taurus)   ENSCING00000011410 (Ciona intestinalis)   Tcp11 (Rattus norvegicus)   Tcp11 (Mus musculus)   CG16721 (Drosophila melanogaster)   SOK1 (Saccharomyces cerevisiae)   TCP11 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term membrane, spermatogenesis, cell differentiation, multicellular organismal development, integral to membrane
InterPro Term Tcp11
UniProt Accession Q8WWU5, D6R9D8, D6R989, D6R8Y5, D6R9R9, D6RAC0, Q5TB88, Q5TB92, D6RBE4, D6RIW4, D6RGY5, D6RGC0, D6RFY8, D6RG02, B7Z7B5, B7Z7G1, B7Z7Q2, E7EP29
Search EB-eye ENSG00000124678
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-803, E-MEXP-1251, E-MTAB-24, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-MTAB-37, E-GEOD-5823, E-GEOD-22152, E-GEOD-20089, ... (12 experiments)

Factor Value U/D Experiments
P3HR1
1
E-MTAB-37
NCIH1155
1
E-MTAB-37
Malme3M
1
E-MTAB-37
NCIH1703
1
E-MTAB-37
DoTc2
1
E-MTAB-37
A673
1
1
E-MTAB-62
64 more value(s).


Cell type

studied in E-AFMX-5, E-MTAB-25, E-GEOD-20033, E-GEOD-3920, E-GEOD-5099, ... (14 experiments)

Factor Value U/D Experiments
mononuclear
1
E-GEOD-13987
M1 macrophage
1
E-GEOD-5099
Leukocytes
1
E-GEOD-21909
macrophage
1
E-GEOD-8286
monocyte
1
E-GEOD-8286
bronchial epithelial
1
E-MTAB-25
23 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-TABM-666, E-GEOD-5563, ... (19 experiments)

Factor Value U/D Experiments
dermatomyositis
1
E-GEOD-5370
liver carcinoma
1
E-MTAB-37
metabolic syndrome
1
E-MTAB-62
lymphoma
1
E-MTAB-62
cervical carcinoma
1
E-MEXP-1331
septic shock
1
E-GEOD-9692
85 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-3284, E-GEOD-3720, E-GEOD-5824, E-MEXP-1335, ... (9 experiments)

Factor Value U/D Experiments
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
glutamine
1
E-MEXP-1335
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
ethanol
1
E-MEXP-2241
Cxcl12
1
E-GEOD-7307
9 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-18995 ... (5 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MEXP-2359, E-GEOD-6236, E-MEXP-958, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Genetic modification
studied in E-MEXP-2340

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-TABM-321

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-22278, E-MEXP-1103, E-GEOD-20505

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1432, E-TABM-666, E-GEOD-19519, ... (15 experiments)

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-21837, E-GEOD-19445, E-GEOD-1343

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

Qrt pcr ereg dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Strain or line
studied in E-TABM-125

Survival time
studied in E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-21909, E-GEOD-19246

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Vehicle
studied in E-GEOD-5258

Processing time: 0.524 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM